Tag: BioCina
BioCina and NovaCina team up to enhance biologics manufacturing capabilities
BioCina, a biologics Contract Development and Manufacturing Organisation (CDMO), has joined hands with NovaCina, a global fill-and-finish CDMO, to establish a strategic alliance aimed at offering integrated drug substance and drug product solutions for biologics developers.
BioCina secures funding to develop manufacturing tech for mRNA vaccine
Australian contract development and manufacturing organisation (CDMO) BioCina has received an AUD 5 million grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to develop enabling technologies for the manufacture of precision mRNA vaccines.
BioCina taps Mark Womack as CEO
Australian contract development and manufacturing organisation (CDMO) BioCina has appointed Mark Womack as the chief executive officer who will be responsible for the continued growth, commercial strategy and organisational culture of the company.
South Australian-made pneumococcal vaccine to undergo human trials
GPN Vaccines, a South Australian biotech company, has successfully developed a new universal vaccine that targets a pneumonia-causing bacterium.
Developed in collaboration with the University...
SA’s needle-free Covid vaccine ready for human trials
Human trials will commence this week on a novel Covid-19 vaccine designed by University of Adelaide researchers and manufactured at the hi-tech BioCina facility...
University of Adelaide and BioCina partnership to accelerate Australia’s COVID-19 vaccine rollout
University of Adelaide has unveiled a plan that could see Australia achieve total COVID-19 vaccine self-reliance within a year.
The University announced a partnership with...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
